ArticleJournal of spine surgery (Hong Kong)2025
Reduction of degenerative anterolisthesis using an expandable interbody device.
Article in Journal of spine surgery (Hong Kong), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Degenerative spondylolisthesis is a condition characterized by back pain and radiculopathy due to nerve root impingement caused by misalignment of adjacent vertebral bodies. Surgical intervention with interbody fusions has been shown to have better outcomes than non-surgical approaches. Traditionally, static implants have been used to aid in arthrodesis of the unstable joint. A recent development in interbody fusion procedures is the use of expandable interbody devices which can expand bidirectionally to conform to endplate irregularities. This allows the spine to decompress naturally to fit each patient's unique anatomy, restoring spinal alignment and reducing spondylolisthesis in an individualized manner. Previous expandable interbody devices were regarded as inferior to their static counterparts due to high rates of non-union. The emergence of newer expandable implants that use a polyester mesh composed of polyethylene terephthalate thread has provided similar rates of fusion among both types of implants. The primary objective of this study was to illustrate the reduction of grade I/II degenerative anterolisthesis through a percutaneous trans-Kambin triangle far lateral approach using a single implant composed of a polyethylene terephthalate thread. Methods: A retrospective chart review was performed on patients who received an oblique far lateral trans-Kambin triangle percutaneous approach with placement of the studied implant to correct a grade I or II spondylolisthesis from 2/9/2018 to 5/26/2021. Demographic information was recorded from the electronic medical record system. Spondylolisthesis slip distance, foraminal height, anterior disc height, and posterior disc height were documented for both the pre-operative and post-operative radiographs. Results: For the 20 patients included in the study, the mean pre-operative spondylolisthesis was 5.2 mm, and the mean post-operative spondylolisthesis was 1.1 mm. The average change in spondylolisthesis was 4.1 mm, an 85.4% reduction. Sixty-five percent of the patients had complete reduction of spondylolisthesis with a post-operative measurement of 0 mm. Significant improvements were also observed in foraminal height as well as anterior and posterior disc height. Conclusions: The use of the expandable interbody device using a far lateral trans-Kambin approach displayed exceptional ability to reduce grade I/II degenerative spondylolisthesis. Radiographically, this surgical combination provided excellent, long-term decompressive abilities regarding foraminal height, disc height, and spondylolisthesis reduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.